There seems to be hope for people living with the human immunodeficiency virus (HIV) causes AIDS, a chronic immune system disease as the United State government launched lenacapavir injection.
The Food and Drug Administration (FDA) of the United States said, the “twice-yearly injections” and tablets for treating HIV in adults with multi-drug-resistant infection is a new dawn for people living with the disease.
HIV has a number of long-term effects on the body, including immune system damage and interference with the body’s ability to fight infection and disease.
The disease is fatal and necessitates medical diagnosis as well as lab tests or imaging at all times.
Sunlenca (lenacapavir) has been identified as the drug that will be administered via injections, and experts have described it as a game changer in the treatment of HIV.
In terms of cost, HIV-positive people will now delve deeper. The hope for those infected with HIV has been dimmed by the latest messages emerging over the amount of money needed to get injectables.
 causes AIDS, a chronic immune system disease as){kind=link}